Delivery Order SPE2DB24D2003-SPE2DB25FXLE5
Award Date 7/30/25
Potential Completion Date 7/31/25
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 25 mg tablets (90-count) valued at $5,569.27 under a firm fixed price contract. This award, issued on July 31, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYRBETRIQ (mirabegron) is a beta-3 agonist medication used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for MYRBETRIQ ER 50 MG tablets (quantity: 90-count supply) with a ceiling value of $3,120.05 under a firm fixed price contract. This is a non-set-aside award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion potential value through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of MYRBETRIQ ER 50 mg tablets (90-count quantity) valued at $7,075.56. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The contract is set to be completed by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYRBETRIQ...
- The Defense Logistics Agency awarded a $7,794.93 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count unit). The contract utilizes firm fixed-price pricing with an ultimate completion date of July 29, 2025, and represents a non-competitive, non-set-aside award. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.22 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (30-count supply). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 1, 2025, and represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,512.00 delivery order on July 21, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price contract with a completion date of July 22, 2025, and represents a non-set-aside competitive award. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $13,463.38 delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 MG tablets (90-count) with a completion date of July 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award represents a pharmaceutical supply delivery to support federal medical procurement needs, with performance conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $4,013.94 to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this firm fixed-price contract utilized competitive procedures with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Myrbetriq ER 25 mg tablets (90-count supply) with a ceiling value of $1,023.10. This firm fixed-price delivery order, awarded on July 29, 2025, represents a non-competitive set-aside award and is expected to be completed by July 30, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MYRBETRIQ ER 50 MG tablets. The $5,448.95 contract has a completion date of March 12, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...